Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer
暂无分享,去创建一个
Xiao Zhi | Daxiang Cui | Xianli He | Kan Wang | Yang Song | Chunlei Zhang | Yunsheng Chen | Jingpu Zhang | Kan Wang | D. Cui | Xiao Zhi | H. Fu | Chunlei Zhang | Yunsheng Chen | Fei Pan | Xianli He | Jingpu Zhang | Jian Ni | Hualin Fu | Yue Ma | Haichuan Su | Haichuan Su | Yue Ma | Fei Pan | Jian Ni | Weilin Jin | Weilin Jin | Yang Song
[1] M. Shokrgozar,et al. miR-17-92 cluster: an apoptosis inducer or proliferation enhancer , 2013, Molecular and Cellular Biochemistry.
[2] M. Kudo,et al. Down-Regulation of miR-92 in Human Plasma Is a Novel Marker for Acute Leukemia Patients , 2009, PloS one.
[3] Govindaraju Archunan,et al. MicroRNAs -the Next Generation Therapeutic Targets in Human Diseases , 2013, Theranostics.
[4] H. Espejo,et al. [Gastric cancer]. , 1996, Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru.
[5] M. Pfaffl,et al. A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.
[6] Frank Speleman,et al. A novel and universal method for microRNA RT-qPCR data normalization , 2009, Genome Biology.
[7] C. Croce,et al. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review , 2012, EMBO molecular medicine.
[8] T Kawaguchi,et al. Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma , 2012, British Journal of Cancer.
[9] Alicia Algeciras-Schimnich,et al. Analysis of circulating microRNA: preanalytical and analytical challenges. , 2011, Clinical chemistry.
[10] O. Kent,et al. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes , 2006, Oncogene.
[11] Wei Zhang,et al. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. , 2012, Cancer letters.
[12] P. Hermanek. The superiority of the new International Union Against Cancer and American Joint Committee on Cancer TNM staging of gastric carcinoma , 2000, Cancer.
[13] Jianhua Huang,et al. Regulatory effects of miRNA on gastric cancer cells , 2014, Oncology letters.
[14] Lisa M McShane,et al. Publication of tumor marker research results: the necessity for complete and transparent reporting. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] Yuan Yuan,et al. Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer , 2013, Medical Oncology.
[16] P. Eastman. Annual Report on Status of Cancer from ACS, NCI, CDC, Cancer Registries: Targeted Focus on Latinos Will Likely Improve US Cancer Rates , 2006 .
[17] D. Hoon,et al. Circulating nucleic acids in plasma and serum: past, present and future. , 2004, Current opinion in molecular therapeutics.
[18] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[19] Q. Wu,et al. MiR-19a/b modulate the metastasis of gastric cancer cells by targeting the tumour suppressor MXD1 , 2014, Cell Death and Disease.
[20] Muneesh Tewari,et al. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). , 2010, Methods.
[21] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.
[22] Yingdong Zhao,et al. Strengths and Limitations of Laboratory Procedures for MicroRNA Detection , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[23] S. Fu,et al. Cell-free Circulating miRNA Biomarkers in Cancer , 2012, Journal of Cancer.
[24] Zhaohui Huang,et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer , 2010, International journal of cancer.
[25] M. Reiser,et al. Micro-RNAs as Potential New Molecular Biomarkers in Oncology: Have They Reached Relevance for the Clinical Imaging Sciences? , 2013, Theranostics.
[26] Bing-sheng Li,et al. microRNA-16 represses colorectal cancer cell growth in vitro by regulating the p53/survivin signaling pathway. , 2013, Oncology reports.
[27] A. Ristimäki,et al. Gastric Cancer: Basic Aspects , 2011, Helicobacter.
[28] C. V. D. Velde,et al. Gastric cancer – Authors' reply , 2009, The Lancet.
[29] Xue-mei Ma,et al. Identification of Suitable Reference Genes for qPCR Analysis of Serum microRNA in Gastric Cancer Patients , 2012, Digestive Diseases and Sciences.
[30] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[31] G. Reid,et al. Circulating microRNAs: Association with disease and potential use as biomarkers. , 2011, Critical reviews in oncology/hematology.
[32] D. Ichikawa,et al. Circulating microRNAs in plasma of patients with gastric cancers , 2010, British Journal of Cancer.
[33] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[34] K. Zen,et al. Circulating MicroRNAs: a novel class of biomarkers to diagnose and monitor human cancers , 2012, Medicinal research reviews.
[35] A. Harris,et al. Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma , 2008, British journal of haematology.
[36] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[37] Sang Taek Oh,et al. Expression of Viral MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma , 2006, Journal of Virology.
[38] D. Kang,et al. Identification of Serum MicroRNAs as Novel Non-Invasive Biomarkers for Early Detection of Gastric Cancer , 2012, PloS one.
[39] Min Yan,et al. MiRNA-199a-3p in Plasma as a Potential Diagnostic Biomarker for Gastric Cancer , 2013, Annals of Surgical Oncology.
[40] W. Kang,et al. Treatment strategy for early gastric cancer. , 2012, Surgical oncology.
[41] G. Calin,et al. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. , 2009, Expert opinion on biological therapy.
[42] C. Varon,et al. Gastric cancer: Basic aspects , 2012, Helicobacter.
[43] C. Lockwood,et al. Pre-analytical variables in miRNA analysis. , 2013, Clinical biochemistry.
[44] C. Croce,et al. MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.
[45] R. Paulmurugan. MicroRNAs - A New Generation Molecular Targets for Treating Cellular Diseases , 2013, Theranostics.
[46] Jie He,et al. Annual report on status of cancer in China, 2011. , 2015, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.
[47] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[48] Jackeline Agorreta,et al. microRNA-451 Regulates Macrophage Migration Inhibitory Factor Production and Proliferation of Gastrointestinal Cancer Cells , 2009, Clinical Cancer Research.
[49] Xi Chen,et al. A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. , 2011, European journal of cancer.
[50] Jie He,et al. Annual report on status of cancer in China, 2010. , 2014, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.
[51] Takahiro Ochiya,et al. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis , 2010, Cancer science.
[52] Michael J Kerin,et al. Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer , 2010, Annals of surgery.
[53] S. Bojesen,et al. MicroRNA biomarkers in whole blood for detection of pancreatic cancer. , 2013, JAMA.
[54] R. Robitaille,et al. Circulating miRNAs as sensitive and specific biomarkers for the diagnosis and monitoring of human diseases: promises and challenges. , 2013, Clinical biochemistry.
[55] M. Mayr,et al. Analytical challenges and technical limitations in assessing circulating MiRNAs , 2012, Thrombosis and Haemostasis.